The Administrative Core of the Interdisciplinary Research Unit for Attacking Failure of Antibiotic Treatment
(AFAT) will oversee the day-to-day operations of the Unit, ensuring that the scientific Aims of the Unit are met.
The Core Director, Dr. Tim van Opijnen, will oversee the Core in collaboration with an administrator and a
Synergy Director, Dr. Ralph Isberg. Milestone tracking will be an important duty of the Administrative Core,
and a defined set of these goals has been established to facilitate the timely completion of Specific Aims
detailed in three Research Projects and one Scientific Core. A second important duty will be ensuring scientific
synergy as well as technology transfer between individual projects and the Scientific Core. There will be a
Mentoring Plan established to allow students and fellows to be collaboratively guided within the three Projects,
with special emphasis on bioinformatic training provided by the Scientific Core. An external Scientific Advisory
Board will provide guidance on the conduct of the Unit, including critiques of spending plans and evaluation of
progress toward effective implementation of synergistic relationships. Another important role of the Board will
be to evaluate progress toward milestones, and provide suggestions regarding alternate routes of attacking
problems, when needed. A key responsibility of the Core will be to communicate with NIAID officials regarding
progress in the Unit, as well as organize, prepare and submit annual progress reports. The Core will also plan
for annual meetings attended by other Combatting Antibiotic Resistant Bacteria Interdisciplinary Units
(CARBIRU) and provide resources for travel for of the Team to these annual meetings.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AdherenceAdministratorAdvisory CommitteesAntibiotic TherapyAntimicrobial ResistanceAwardBioinformaticsBudgetsCellsClinicalCollaborationsCombating Antibiotic Resistant BacteriaCommunicationCritiquesDataEnsureEvaluationEventFailureGenomicsGoalsGuidelinesHuman ResourcesIndividualIntellectual PropertyInterdisciplinary StudyLaboratoriesLeadershipLightMentorsMutationNational Institute of Allergy and Infectious DiseaseOccupational activity of managing financesPatientsPerformancePersonsPlayPrincipal InvestigatorProgress ReportsResearchResearch PersonnelResearch Project GrantsResistanceResourcesRoleRouteServicesStudentsSuggestionTechnology TransferTrainingTravelTreatment FailureU-Series Cooperative AgreementsVisionclinical materialmeetingsnew technologyoperationprogramssuccesssymposiumsynergismvirtual
National Institute of Allergy and Infectious Diseases
CFDA Code
DUNS Number
076593722
UEI
Z1L9F1MM1RY3
Project Start Date
12-September-2022
Project End Date
30-June-2026
Budget Start Date
01-July-2024
Budget End Date
30-June-2025
Project Funding Information for 2024
Total Funding
$110,705
Direct Costs
$62,194
Indirect Costs
$48,511
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Allergy and Infectious Diseases
$110,705
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 7U19AI158076-03 8509
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 7U19AI158076-03 8509
Patents
No Patents information available for 7U19AI158076-03 8509
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 7U19AI158076-03 8509
Clinical Studies
No Clinical Studies information available for 7U19AI158076-03 8509
News and More
Related News Releases
No news release information available for 7U19AI158076-03 8509
History
No Historical information available for 7U19AI158076-03 8509
Similar Projects
No Similar Projects information available for 7U19AI158076-03 8509